Clinical Research Fellowship: Awardees & Reports

2018 Fellowship 

Cardiotoxicity Related to Systemic Anti-HER2 Therapies: sub-analysis of ALTTO and APHINITY trials


Fellow: Daniel Eiger
Home institute: Centro Paulista de Oncologia, Sao Paolo, Brazil
Host institute: Institute Jules Bordet, Brussels, Belgium
Sponsor: Novartis

2017 Fellowship

Health Behaviors and Long-term Treatment Toxicity Among Breast Cancer Survivors: A Quantitative Analysis in the French Prospective CANTO Cohort


Fellow: Antonio Di Meglio 
Home Institute: IRCCS AOU San Martino, Genoa, Italy
Host institute: Institut Gustave Roussy, Villejuif, France
Sponsor: ESMO

A Phase I-II Investigation of Pembrolizumab in Combination with Oral Metronomic Cyclophosphamide in Patients with Locally Recurrent, Inoperable, and/or Metastatic Inflammatory Breast Cancer with Lymphangitic Spread to the Chest Wall


Fellow: Bruno Duso 
Home Institute: Hospital Moinhos de Vento, Porto Alegre, Brazil
Host institute: Istituto Europeo di Oncologia, Milan, Italy
Sponsor: ESMO

Download the report

LAsting Symptoms after Esophageal Resection (LASER)


Fellow: Sheraz Markar 
Home Institute: St. Mary's Hospital Imperial College, London, United Kingdom
Host institute: Karolinska Instituttet, Stockholm, Sweden
Sponsor: Novartis

2016 Fellowship

Inflammation markers and prognostic model of survival and toxicity in patients with advanced pancreatic cancer (APC) receiving palliative Gemcitabine-based chemotherapy: insights from the SAKK 44/00-CECOG/PAN.1.3.001


Fellow: Piera Gargiulo
Home institute: Istituto Nazionale Tumori- I.R.C.C.S - Fondazione Pascale, Napoli, Italy
Host institute: Swiss Group for Clinical Cancer Research SAKK, Bern, Switzerland
Sponsor: Novartis

Download the report

Read the publication

2015 Fellowship

Study of prognostic factors in patients with BRAF-mutant metastatic melanoma treated with targeted therapies


Fellow: Sara Valpione
Home Institute: University of Padova, Italy
Host Institute: The Christie NHS Foundation Trust, University of Manchester, United Kingdom
Sponsor: Novartis 

2014 Fellowship

Co-targeting of AKT and the Androgen Receptor for Advanced Prostate Cancer

Michael Kolinsky

Fellow: Michael Kolinsky
Home Institute: University of Alberta Cross Cancer Institute, Edmonton, Alberta, Canada
Host Institute: The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK
Sponsor: Novartis  

2013 Fellowships

Molecular resistance following personalised therapy in colorectal cancer (FOCUS-4 clinical fellow)

Tal Grenader

Fellow: Tal Grenader
Home Institute: Shaare Zedek Medical Centre, Jerusalem, Israel
Host Institute: UCL, Cancer Institute, University College London, United Kingdom
Sponsor: Novartis  

Metabolomic study in renal cell carcinoma (RCC): patterns of relapsed and follow up

Guillermo Antonio De Velasco Oria

Fellow: Guillermo Antonio De Velasco Oria
Home Institute: University Hospital 12 De Octubre, Medical Oncology, Madrid, Spain
Host Institute: Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Sponsor: Novartis

2011 Fellowship

Association between insulin resistance and pathologic response to neoadjuvant chemotherapy among women with operable hormone receptor negative breast cancer

 Alejandra Alonso

Fellow: Alejandra Armengol Alonso
Home Institute: Instituto Nacional De Ciencias Medicias y Nutricion, Mexico City, Mexico
Host Institute: Barcelona Hospital Universitari, Barcelona, Spain
Sponsor: Novartis

Download the report

2010 Fellowships

Treatment of naïve and fludarabine-refractory CLL in the TCL-1 mouse model with IPI-926 and other hedgehog pathway inhibitors

Fellow: Michael Baumann
Home Institute: Department of Medical Oncology, Kantonsspital, St. Gallen, Switzerland
Host Institute:Laboratory of Molecular Biology and Immunology CLL, Dept of Haematology and Oncology, University of Cologne, Germany
Sponsor: ESMO

Download the report

Prostate Cancer Genetics and targeted screening

Fellow: Elena Castro Marcos
Home Institute: Centro de Investigacion del Cancer, Hospital Universitario de Salamanca, Spain
Host Institute: Royal Marsden Hospital NHS Trust, and The institute of Cancer Research, London, United Kingdom
Sponsor: Novartis

Download the report